Skip to content

Trupanion

US · TRUP #3196 by market cap
35.56 -0.31 -0.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • Total institutional ownership rose 1.1 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
94.87% +1.11pp
Institutions
256
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund60.63%
Public Company14.92%
Private Company10.57%
Hedge Fund7.12%
Individual/Insider5.62%
Government Pension Fund1.00%
Insurance Company0.32%
Family Office/Trust0.25%
Other0.66%

Top holders as of 2026-09-30

BlackRock 13.19% · 5.71M sh
Felix Holdings B.V. 9.93% · 4.30M sh
Aflac Incorporated 8.40% · 3.64M sh
Nielsen Capital Management Fondsmaeglerselskab A/S 6.71% · 2.90M sh
Capital Research 4.97% · 2.15M sh
FMR 4.49% · 1.94M sh
Vanguard Portfolio Management, LLC 4.13% · 1.79M sh
Polar Capital Holdings Plc 4.04% · 1.75M sh
Vanguard Capital Management, LLC 3.45% · 1.49M sh
Darryl Graham Rawlings 3.38% · 1.46M sh
State Street Global Advisors 3.11% · 1.37M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 19 buys · 31 sells

NameRoleStake
Darryl Graham Rawlings Founder & Chair of the Board 3.38%
Howard Rubin Independent Director 0.54%
Margaret Rosemary Tooth Chief Executive Officer 0.43%
Murray Low Lead Independent Director 0.36%
Steve Weinrauch Chief Veterinary & Product Officer 0.19%
Asher Bearman Chief Legal Officer 0.17%
Emily Dreyer Former Chief Revenue Officer 0.08%
John Gallagher Chief Operating Officer 0.08%
Simon Wheeler Executive Vice President of International Business 0.06%
Jacqueline Davidson Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-09 Murray Low Lead Independent Director Open Market Disposition -6,537 $34.21
2026-11-08 Howard Rubin Independent Director Open Market Disposition -30,000 $35.23
2026-11-08 Margaret Rosemary Tooth Chief Executive Officer Automatic Disposition -2,000 $36.44–36.92
2026-10-27 John Gallagher Chief Operating Officer Automatic Disposition -431 $29.12
2026-10-08 Margaret Rosemary Tooth Chief Executive Officer Automatic Disposition -1,000 $25.84
2026-09-27 John Gallagher Chief Operating Officer Automatic Disposition -431 $22.92
2026-09-10 Margaret Rosemary Tooth Chief Executive Officer Automatic Disposition -1,000 $25.00
2026-08-27 John Gallagher Chief Operating Officer Automatic Disposition -3,604 $29.70
2026-08-25 Fawwad Qureshi Chief Financial Officer Derivative Exercise and Sale -3,750 $30.01–31.84
2026-08-25 Fawwad Qureshi Chief Financial Officer Open Market Disposition -3,858 $30.01
2026-08-24 Asher Bearman Chief Legal Officer Derivative Exercise and Sale -841 $31.76–31.84
2026-08-24 Asher Bearman Chief Legal Officer Derivative Exercise and Retained +1,769 --
2026-08-24 Margaret Rosemary Tooth Chief Executive Officer Derivative Exercise and Sale -7,491 $31.76–31.84
2026-08-24 Margaret Rosemary Tooth Chief Executive Officer Derivative Exercise and Retained +11,551 --
2026-08-24 Steve Weinrauch Chief Veterinary & Product Officer Derivative Exercise and Sale -1,181 $31.76–31.84
2026-08-24 Steve Weinrauch Chief Veterinary & Product Officer Derivative Exercise and Retained +3,678 --
2026-08-24 John Gallagher Chief Operating Officer Derivative Exercise and Sale -1,651 $31.76–31.84
2026-08-24 John Gallagher Chief Operating Officer Derivative Exercise and Retained +5,143 --
2026-08-24 Simon Wheeler Executive Vice President of International Business Derivative Exercise and Sale -1,085 $31.76–31.84
2026-08-24 Simon Wheeler Executive Vice President of International Business Derivative Exercise and Retained +1,088 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Trupanion discussion 0 comments

Add a comment